to describe the pharmacotherapeutic profile of users of the Specialized Program for Pharmaceutical Assistance, and to measure the expenditure on the most prevalent and the most expensive medications.
descriptive study conducted in São Leopoldo-RS, Brazil, with secondary data regarding information about requests accepted in 2014, through administrative proceedings; delivery notes of the State Health Department/RS were used to assess the costs.
1,528 users were included in the study, mostly women (56.7%), and the average age was 52 years (standard deviation=17.9); the most frequent diagnoses were allergic asthma (17.1%), chronic kidney disease (11.5%) and rheumatoid arthritis (8.4%); the most prevalent drug was budesonide+formoterol fumarate (18.3%); among the most prevalent drugs, the highest total monthly expense was with epoetin alfa (BRL37,922.34) and among the most expensive drugs, infliximab (BRL72,503.28).
the data show the importance of the Specialized Program for Pharmaceutical Assistance in the high-cost treatment of highly prevalent.
Pharmacology, Toxicology and Pharmaceutical Science
10
28%
Medicine and Dentistry
5
14%
Nursing and Health Professions
2
6%
Arts and Humanities
1
3%
Immunology and Microbiology
1
3%
Other
1
3%
Unknown
16
44%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2018.
All research outputs
#21,952,810
of 27,788,586 outputs
Outputs from Epidemiologia e Serviços de Saúde
#285
of 462 outputs
Outputs of similar age
#256,246
of 346,203 outputs
Outputs of similar age from Epidemiologia e Serviços de Saúde
#9
of 13 outputs
Altmetric has tracked 27,788,586 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 462 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,203 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.
